Literature DB >> 22017267

Decision support for sensible dosing in electronic prescribing systems.

J J Coleman1, U Nwulu, R E Ferner.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: The sensible dosing of medicines can ensure that patients receive neither excessive doses leading to toxicity nor inappropriately low doses leading to undertreatment. Computerized prescribing systems with embedded decision support can check doses during prescription order entry and display alerts when the prescribed doses are out of range. We have been unable to identify any scheme for the systematic addition of dosing information to CPOE systems. We used pharmacological data to design an algorithm for dose range checking that we tested on a subset of medicines in an electronic prescribing system to ensure that the rules could be implemented in practice.
METHODS: We drafted an initial algorithm based on pharmacological principles, tested it on a subset of frequently prescribed drugs in an electronic prescribing system and then refined it. We considered which clinical decision support functions systems would require to be maximally effective. RESULTS AND DISCUSSION: The final algorithm contained eleven broad factors. We tested it on 30 drug-route-form combinations, and it accommodated the information for all of these combinations. We also identified a variety of system functions that would be required for comprehensive dosing decision support. WHAT IS NEW AND
CONCLUSION: The dose range checking algorithm that we have derived from first principles will allow the clinical workflow and warnings to be constructed more effectively within systems to enhance patient safety. This will form a basis for the development of optimal schemes for adding decision support to prescribing systems.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017267     DOI: 10.1111/j.1365-2710.2011.01310.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  4 in total

1.  Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Authors:  Teresa M Salgado; Blanca Arguello; Fernando Martinez-Martinez; Shalom I Benrimoj; Fernando Fernandez-Llimos
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

2.  Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit.

Authors:  Adrian Wong; Christine Rehr; Diane L Seger; Mary G Amato; Patrick E Beeler; Sarah P Slight; Adam Wright; David W Bates
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

3.  Definition of variables required for comprehensive description of drug dosage and clinical pharmacokinetics.

Authors:  Anna V Medem; Hanna M Seidling; Hans-Georg Eichler; Jens Kaltschmidt; Michael Metzner; Carina M Hubert; David Czock; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2017-02-14       Impact factor: 2.953

4.  On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop.

Authors:  Jamie J Coleman; Heleen van der Sijs; Walter E Haefeli; Sarah P Slight; Sarah E McDowell; Hanna M Seidling; Birgit Eiermann; Jos Aarts; Elske Ammenwerth; Ann Slee; Robin E Ferner; Robin E Ferner; Ann Slee
Journal:  BMC Med Inform Decis Mak       Date:  2013-10-01       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.